Skip to content

Advertisement

  • Poster presentation
  • Open Access

Clinical presentations and molecular basis of complement C1R mutation in a large turkish family

  • 1,
  • 2,
  • 3,
  • 3,
  • 4,
  • 4 and
  • 1
Pediatric Rheumatology201412 (Suppl 1) :P116

https://doi.org/10.1186/1546-0096-12-S1-P116

  • Published:

Keywords

  • Sanger Sequencing
  • Turkish Patient
  • Consanguineous Family
  • Female Sibling
  • Complement Deficiency

Introduction

Inherited deficiencies of complement components can result in autoimmunity. Early age of onset, prominent cutaneous manifestations, and presence of anti-Ro antibodies are features suggestive of a complement deficiency. SLE-associated deficiencies in subcomponents of the C1 complex, C1r and/or C1s, were described 4 decades ago, however the molecular basis and functional aspects of the complement deficiency have not been clearly determined.

Objectives

The aim of this study was to identify the cause of presumably recessively inherited form of SLE and/or lupus-like syndrome (LLS) in a consanguineous family from Turkey.

Methods

We studied 2 pairs of young female siblings(4 patients), who presented with Lupus-like syndrome but with a significant phenotypic variability and differences in the disease severity. They shared a history of episodes of malar and/or generalized rash and ANA positivity, while anti-dsDNA were negative in all four. Renal involvement was prominent in one pair of siblings and one patient developed CNS manifestations including convulsion.

DNA samples from the affected patients, their unaffected parents and siblings were isolated from whole blood. We performed whole-exome sequencing in 9 samples from this family and Sanger sequencing in other family members.

Results

We identified a homozygous frameshift mutation in the CR1 gene (NM_001733.4;c.1331delT; p.Pro445Leufs*11), encoding complement 1r subunit, in all 4 affected siblings. The homozygous p.Pro445Leufs*11 mutation was validated with Sanger sequencing in all four patients while their unaffected parents and siblings were either heterozygous carriers or non-carriers. One 9y old sibling was identified as homozygous for the mutation but is yet unaffected. Despite the same genotype the affected patients have variable phenotypes concerning disease features, severity, disease outcome, thus suggesting a role for other modifying alleles or epigenetic factors.

Conclusion

Our findings show the second molecular evidence that loss-of-function mutations in C1R are the cause of SLE or lupus-like syndrome. We report a novel genetic defect in the C1r complement protein leading to a recessive form of familial SLE/LLS in the Turkish population. This mutation is likely present in the general population and it should be included in diagnostic evaluation of Turkish patients with early onset SLE.

We plan extensive biochemical, immunologic, and functional assays to assess the impact of this pathogenic mutation on complement function, apoptosis, neutrophil and B cell biology.

Disclosure of interest

None declared.

Authors’ Affiliations

(1)
Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, USA
(2)
Pedaitric Rheumatology, İstanbul University, Cerrahpasa Medical Faculty, İstanbul Turkey, Istanbul, USA
(3)
Pedaitric Rheumatology, İstanbul University, Cerrahpasa Medical Faculty, İstanbul Turkey, Istanbul, Turkey
(4)
FMF Arthritis Vasculitis and Orphan disease Research in pediatric rheumatology (FAVOR), Gulhane Military Medical Academy, Ankara, Turkey

Copyright

© Demirkaya et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement